LIVONGO HEALTH INC - NOTE 0.875% 6/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2021 to Q2 2025

Type / Class
Debt / NOTE 0.875% 6/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of LIVONGO HEALTH INC - NOTE 0.875% 6/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2025 Q2 $0 $0 -$561,504,705 0
2025 Q1 $565,788,000 $561,598,738 +$427,073 99.17% 24
2024 Q4 $565,363,825 $553,379,127 +$10,865,423 97.81% 22
2024 Q3 $556,304,000 $539,866,316 +$1,606,969 96.94% 23
2024 Q2 $555,346,000 $529,802,477 +$1,699,226 95.25% 25
2024 Q1 $553,738,000 $524,683,290 +$65,475,451 94.6% 27
2023 Q4 $493,423,000 $462,976,874 +$4,160,403 93.69% 31
2023 Q3 $491,241,679 $459,006,690 +$39,992,852 91.51% 30
2023 Q2 $453,414,000 $410,711,314 +$18,805,876 90.5% 34
2023 Q1 $432,984,793 $383,375,365 -$3,570,541 88.51% 34
2022 Q4 $427,241,900 $382,911,865 -$61,503,445 87.53% 33
2022 Q3 $473,034,930 $397,771,864 +$11,476,608 83.67% 36
2022 Q2 $457,959,581 $410,954,671 +$11,564,892 84.37% 35
2022 Q1 $444,096,000 $447,710,491 +$20,521,359 100.7% 29
2021 Q4 $409,132,000 $467,306,247 -$192,503,922 114.14% 25
2021 Q3 $561,720,525 $739,297,046 +$72,893,282 131.71% 28
2021 Q2 $503,360,000 $796,122,544 +$785,248,093 158.3% 31